Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating an IL4Rα monoclonal antibody for uncontrolled seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• IL4Rα monoclonal antibody (IL4Rα monoclonal antibody)

Snippet

Sponsor: Zheng Liu ENT | Conditions: Allergic Rhinitis | Phase 2 | Status: UNKNOWN